| AAUTX | VIVAX | AAUTX / VIVAX | |
| Total Expense Ratio | 0.84 | 0.17 | 494% |
| Annual Report Gross Expense Ratio | 0.84 | 0.17 | 494% |
| Fund Existence | 26 years | 33 years | - |
| Gain YTD | 15.379 | 14.025 | 110% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2000 | 3000 | 67% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.24B | 216B | 2% |
| Annual Yield % from dividends | 1.07 | 1.93 | 56% |
| Returns for 1 year | 14.13 | 12.66 | 112% |
| Returns for 3 years | 34.31 | 37.81 | 91% |
| Returns for 5 years | 51.02 | 64.99 | 79% |
| Returns for 10 years | 95.12 | 134.86 | 71% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MVISX | 55.32 | 0.23 | +0.42% |
| Patient Opportunity IS | |||
| SCIUX | 12.33 | 0.03 | +0.24% |
| Invesco Income Advantage U.S. Fund R5 | |||
| IEGAX | 21.23 | 0.03 | +0.14% |
| Invesco International Small Company A | |||
| LGPSX | 41.57 | N/A | N/A |
| ProFunds Large Cap Growth Svc | |||
| LMGTX | 61.41 | -0.01 | -0.02% |
| ClearBridge International Growth C | |||